Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Catheter Precision ( (VTAK) ) is now available.
On December 31, 2025, Catheter Precision, Inc. executed second amendments to each of its outstanding 8% short-term promissory notes, extending their maturity dates from January 31, 2026, to January 31, 2029, for notes totaling $1 million held by CEO David A. Jenkins and FatBoy Capital, L.P., and to January 31, 2028, for a $500,000 note held by the Jenkins Family Charitable Institute. The transaction underscores the company’s reliance on and continued financial backing from related parties closely tied to its chief executive, consolidating long-term insider financing while also highlighting the concentration of economic interests and governance influence among Jenkins and his affiliates.
The most recent analyst rating on (VTAK) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Catheter Precision stock, see the VTAK Stock Forecast page.
Spark’s Take on VTAK Stock
According to Spark, TipRanks’ AI Analyst, VTAK is a Neutral.
The score is primarily driven by weak financial performance—declining revenue, ongoing losses, and negative free cash flow. Technicals further weigh on the rating with a clear downtrend and negative momentum, despite oversold readings. Valuation provides limited offset because negative earnings make P/E less informative and there is no dividend support.
To see Spark’s full report on VTAK stock, click here.
More about Catheter Precision
Catheter Precision, Inc. operates in the medical device sector, developing and commercializing products for cardiac procedures, including its LockeT device. The company’s leadership and related entities, notably Executive Chair and CEO David A. Jenkins, his affiliates such as FatBoy Capital, L.P., and the Jenkins Family Charitable Institute, hold equity interests, stock options, royalty rights tied to LockeT sales, and play key roles in both governance and operations, including involvement by Jenkins’ adult daughter as non-executive chief operating officer.
Average Trading Volume: 54,745
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.35M
Learn more about VTAK stock on TipRanks’ Stock Analysis page.